VECTURA
Philip Morris weighs cigar sale amid smoke-free shiftPhilip Morris International is considering a sale of its US cigar business, with hopes of fetching over $1 billion. This move aligns with t...
Philip Morris to sell Vectura for $198 mln after health shift criticismPhilip Morris International's Vectura Fertin Pharma has announced the sale of its asthma inhaler maker Vectura Group to Molex Asia Holdings...
European stocks weighed down by weak commoditiesOil majors Royal Dutch Shell, BP and TotalEnergies slipped about 1% each as crude prices fell more than 3% on fears that pandemic-led curbs...
Tobacco group Philip Morris buys maker of inhalersThe Marlboro-maker will pay 150 pence per share in cash, valuing Vectura at £1.0 billion ($1.4 billion, 1.2 billion euros), the pair said i...
UK pharma group Vectura agrees $1.4 billion takeover by CarlyleVectura's Chairman Bruno Angelici said the company had made strong progress since embarking on a strategy in 2019 to become a leading inhal...
Cipla jumps 8% on completing Phase-3 clinical study of asthma drugThe generic would be used for treatment of asthma and chronic obstructive pulmonary disease.
Load More